Additional information
| Active substance | Human Growth Hormone |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Hormone levels (LH, FSH) |
| Also known as | GnRH agonist implant |
| WAREHOUSE | International Warehouse 3 |
| Blood pressure | No significant effects |
| Trade name | Suprelorin, Ovuplant |
| Storage conditions | Store at controlled room temperature, protect from light |
| Chemical name | Deslorelin acetate |
| Formula | C64H83N17O12В·C2H4O2 |
| Substance class | Gonadotropin-releasing hormone agonist (GnRH agonist) |
| Main action | Increases the production of gonadotropins |
| Half-life | 2-3 hours |
| Dosage (medical) | Typically, 2.1 mg implant every 6 months |
| Dosage (sports) | Not applicable |
| Effects | Induces a temporary decrease in gonadotropin secretion |
| Side effects | Local injection site reactions, altered testosterone levels, potential bone density reduction |
| Use in sports | Not typically used or recommended in sports |
| Manufacturer | Beligas |
FUCIDIN 500 mg Abdi Ibragim
Thyromazol 5 mg Abdi Ibragim
Tavanic 500 mg Sanofi
Ovigil 5000IU Sanzyme
AVELOX 400 Bayer
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Clenbuterol 50 mcg Cygnus
Champix Starter Pack Pfizer 

Reviews
There are no reviews yet.